This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Brineura
  • /
  • A Phase 1/2 Open-Label Dose-Escalation Study to Ev...
Clinical trial

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease

Read time: 2 mins
Last updated:1st Sep 2013
Identifier: NCT01907087
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest